Investment
Features
FeesSafety
Academy
More
Pluang+

Compare McDonald's Corp (MCD) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

McDonald's CorpTrade
State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

McDonald's Corp vs State Street SPDR S&P Biotech ETF — how do they compare? McDonald's Corp trades at $271.87 (market cap $194.00B), while State Street SPDR S&P Biotech ETF trades at $159.12. The key difference: McDonald's Corp pays a 2.71% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, McDonald's Corp nearer its low. Which is the better fit depends on your goals.

MCDXBI
Market Cap
$194.00B
Volume
2,230,036
Sector
Consumer CyclicalBroad Market / Factor
52-Week High
$341.06$164.28
52-Week Low
$262.80$86.92
Enterprise Value
$247.77B
Dividend Yield
2.71%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

McDonald's Corp

McDonald's (MCD) trades at $273.72, down 0.28% on the day, with a neutral technical signal and strong fundamentals including a 31.72% net margin and consistent earnings beats. The company recently unveiled its 'McDonald's NEXT' growth strategy focusing on automation and menu innovation to drive future performance. Revenue growth remains steady, with 2025 revenue at $26.89 billion.

Outlook is positive with a consensus price target of $322.45 offering 17.8% upside, supported by 60% analyst buy ratings. Risks include inflationary pressures on franchisee margins and high long-term debt of $38.42 billion. The stock presents a value opportunity with stable dividends and strategic initiatives aimed at enhancing competitiveness.

State Street SPDR S&P Biotech ETF

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About McDonald's Corp

McDonald's Corporation franchises and operates fast-food restaurants in the global restaurant industry. The Company's restaurants serves a variety of value-priced menu products in countries around the world.

Read more on MCD

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.

Read more on XBI